Oksovell

Oksovell

Manufacturer:

Novell Pharma

Marketer:

Novell Pharma
Concise Prescribing Info
Contents
Oxomemazine HCl 1.65 mg, guaifenesin 33.3 mg
Indications/Uses
Reduce cough w/ sputum accompanied by allergic reaction.
Dosage/Direction for Use
Adult & childn >12 yr (>40 kg) 10 mL 4 times daily. Childn 10-12 yr (30-40 kg) 10 mL 3-4 times daily, 6-10 yr (20-30 kg) 10 mL 2-3 times daily, 2-6 yr (10-20 kg) 5 mL 2-3 times daily.
Administration
Should be taken on an empty stomach.
Contraindications
Hypersensitivity to antihistamines. History of agranulocytosis, risk of urinary retention related to urethroprostatic disorders & closed-angle glaucoma. 1st trimester of pregnancy & lactation.
Special Precautions
CV disorders. Monitor clinical & EEG in epileptics. Avoid sun exposure during treatment. Hepatic & renal impairment. Rule out bronchial asthma & GERD prior to use in childn. Not to be used in childn <2 yr. Elderly.
Adverse Reactions
Sedation or drowsiness; anticholinergic effects eg, dry mucous membranes, constipation, mydriasis, cardiac palpitations & risk of urinary retention; orthastatic hypotension; impaired balance & accommodation; vertigo; memory or conc impairment, motor incoordination & tremor mental confusion & hallucinations. Erythema, eczema, pruritus, purpura, giant urticaria, edema, anaphylactic shock, photosensitization, leukopenia, neutropenia, thrombocytopenia, hemolytic anemia.
Drug Interactions
Increased sedative effect w/ alcohol. Increased risk of arrhythmia w/ sultopride. CNS depressants, atropine & other atropine-like substances.
MIMS Class
Cough & Cold Preparations
ATC Classification
R06AD08 - oxomemazine ; Belongs to the class of phenothiazine derivatives used as systemic antihistamines.
R05CA03 - guaifenesin ; Belongs to the class of expectorants. Used in the treatment of wet cough.
Presentation/Packing
Form
Oksovell syr
Packing/Price
60 mL x 1's (Rp30,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in